Navigation Links
CBR Pharma Insights' Latest Report, The New Era of Healthcare Reform - Supporting Revenue Growth through Understanding & Adaptation
Date:7/1/2010

In the latest report from CBR Pharma Insights, the new healthcare reform legislation which was finally passed earlier this year is analyzed to provide pharmaceutical & biotech companies with a comprehensive set of tools to support their current and future business plans.

(PRWEB) July 1, 2010 -- After a hotly contested national debate, healthcare reform legislation was passed in the spring of 2010. The legislation contains many long-term benefits for the pharmaceutical industry, but the industry must continue to play an active role in legislation implementation to ensure those benefits are realized.

Through the new laws, there are both wins and losses for the pharmaceutical industry, such as changes effecting Medicare/Medicaid, health insurance coverage expansion & protection, taxation and patent protection. However, on balance most changes hold significant long-term potential for the industry.

While pharma played a very important role in promoting health reform during the debate over change, the work is not done. Many of the greatest potential benefits of the legislation – including extending healthcare coverage to 32 million more Americans – will come down the road. Thus, it is crucial for pharma to remain involved with the healthcare reform roll-out going forward.

Use CBR Pharma Insights' new report, "The New Era of Healthcare Reform - Supporting Revenue Growth through Understanding and Adaptation" to:

 
  • Analyze the possible impact that the new healthcare reform legislation could have on your company’s future growth potential
  • Assess the role pharmaceutical companies need to play to best ensure that all potential benefits are actually realized
  • Learn the pitfalls for the pharmaceutical industry to avoid as the new legislation is rolled-out
  • Identify the opportunities for growth in the new reform environment
  • Understand the ways the new healthcare reform bill can help change how healthcare is delivered in the United States

For more information about this report, please go to: http://www.cbrpharmainsights.com/inner/StrategicVisionProducts/CBRSV014pg.html

About CBR Pharma Insights - CBR Pharma Insights is a strategic market research firm whose mission is to empower companies to make the best business decisions possible through providing them with quality, innovative market research solutions. www.cbrpharmainsights.com

###

Read the full story at http://www.prweb.com/releases/2010/07HealthcareReform/prweb4211594.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Pharmalink AB Closes Deal With Grifols SA for the Acquisition of the Xepol(R) Programme for the Treatment of Post-Polio Syndrome
2. Therapure Biopharma Inc. Signs Biomanufacturing Contract with Diamedica Incorporated
3. Dragon Pharma announces date of special meeting
4. Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life
5. Progenika Biopharma Grants Grifols World-Wide Distribution Rights for the BLOODCHIP® Genotyping Test for Blood Donors
6. Angiotech Pharmaceuticals Announces Conference Call and Webcast
7. Three Top 20 Pharmaceutical Companies Select iCardiac as Preferred Vendor
8. Sosei to Acquire Activus Pharma
9. OncoGenex Pharmaceuticals Announces Initiation of a Phase 3 Trial in Men with Metastatic Prostate Cancer
10. Therapure Biopharma Inc. Signs Biomanufacturing Contract with ProChon Biotech Ltd.
11. Melissa Kemp, Ph.D., Wins the Council for Systems Biology in Boston (CSB2) Award Sponsored by Merrimack Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CBR Pharma Insights' Latest Report, The New Era of Healthcare Reform - Supporting Revenue Growth through Understanding & Adaptation 
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life ... for the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan ... The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... of medical marijuana products targeting the needs of consumers who are incorporating medical ... takes place in Phoenix, Arizona. , As operators of two successful Valley dispensaries, ...
(Date:10/6/2017)... ... October 06, 2017 , ... The HealthTech Venture ... sector at their fourth annual Conference where founders, investors, innovative practitioners and collaborators ... ELEVATE pitch competition showcasing early stage digital health and med tech companies. , ...
Breaking Biology Technology:
(Date:5/16/2017)... 16, 2017  Veratad Technologies, LLC ( www.veratad.com ), ... and identity verification solutions, announced today they will participate ... May 15 thru May 17, 2017, in ... Trade Center. Identity impacts the lives ... today,s quickly evolving digital world, defining identity is critical ...
(Date:4/18/2017)... Inc., a global expert in SoC-based imaging and computing solutions, has ... features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® ... be showcased during the upcoming Medtec Japan at Tokyo Big Sight ... Las Vegas Convention Center April 24-27. ... Click here for an image of the ...
(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
Breaking Biology News(10 mins):